Delivery Order SPE2DB22D1052-SPE2DB24FU9UJ

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $8.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,342.21 to Amerisourcebergen Drug Corp's Corporate Office Division to provide 4564830085 ! COSOPT PF EYE DROPS 15S. This contract has a period of performance through June 7, 2024 and is a Firm Fixed Price contract. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 to supply a comprehensive range of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,348.83 firm-fixed-price contract is for the supply of COSOPT EYE DROPS 10ML, a prescription medication. The delivery order has a completion date of June 12, 2025 and is not associated with any set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of COSOPT EYE DROPS 10ML to the Defense Logistics Agency. The $1,144.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 11, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract that Amerisourcebergen holds with the Defense Logistics Agency Troop Support...
The Defense Logistics Agency (DLA) awarded a $10,399.80 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564326082 COSOPT EYE DROPS 10ML. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp's Corporate Office Division serves as the prime contractor and leverages its parent company's extensive pharmaceutical distribution capabilities to fulfill government contracts, particularly for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,530.51, is a Firm Fixed Price Delivery Order for the supply of COSOPT PF EYE DROPS 15S. The contract has an ultimate completion date of June 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distribution company, for the provision of Cosopt eye drops. The contract is a Delivery Order valued at $2,965.60, with a firm fixed price and an ultimate completion date of April 17, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COSOPT eye drops. The $1,606.98 firm fixed-price delivery order contract has an ultimate completion date of October 22, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, a for-profit organization, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,576.43, is for the delivery of COSOPT PF Eye Drops 15S, a pharmaceutical product. The contract is a Delivery Order under the DLA's Indefinite Delivery Contract (IDC) with Cencora, Inc., doing business as Amerisourcebergen, valued at up to $999,999,999.00. This IDC serves as the primary...
This federal contract award is for the delivery of Cosopt eye drops, a prescription medication, to the Defense Logistics Agency (DLA) by the prime contractor Amerisourcebergen Drug Corp. The $2,971.99 firm fixed-price delivery order has a completion date of May 21, 2024. Amerisourcebergen is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the DLA. The company holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of COSOPT EYE DROPS 10ML. The contract has a ceiling value of $1,792.07 and a completion date of April 4, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
  • SPE2DB22D1052
    Indefinite Delivery Contract
  • SPE2DB22D1052-SPE2DB24FU9UJ
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $8,146.06 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of COSOPT EYE DROPS 10ML. This order was placed under the DLA Troop Support Medical Indefinite Delivery Contract, a $999,999,999 vehicle that provides a wide range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is scheduled for completion by September 19, 2024. Amerisourcebergen's extensive supply chain and distribution capabilities enable it to efficiently deliver essential pharmaceutical products to various federal healthcare providers, including military treatment facilities and veterans' hospitals.

Generated 12/18/24, 9:34 AM